Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52%) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87%) and NOTCH1 mutations (62%) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or select molecular lesions influencing outcome.

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia / Rossi, D; Spina, Vincenzo; Bomben, R; Rasi, S; Dal Bo, M; Bruscaggin, A; Rossi, Fm; Monti, S; Degan, M; Ciardullo, C; Serra, R; Zucchetto, A; Nomdedeu, J; Bulian, P; Grossi, A; Zaja, F; Pozzato, G; Laurenti, L; Efremov, Dg; Di Raimondo, F; Marasca, Roberto; Forconi, F; Del Poeta, G; Gaidano, G; Gattei, Valter. - In: BLOOD. - ISSN 1528-0020. - STAMPA. - 121:24(2013), pp. 4902-4905. [10.1182/blood-2013-02-486209]

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

SPINA, VINCENZO;MARASCA, Roberto;GATTEI, VALTER
2013

Abstract

Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52%) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87%) and NOTCH1 mutations (62%) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or select molecular lesions influencing outcome.
2013
121
24
4902
4905
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia / Rossi, D; Spina, Vincenzo; Bomben, R; Rasi, S; Dal Bo, M; Bruscaggin, A; Rossi, Fm; Monti, S; Degan, M; Ciardullo, C; Serra, R; Zucchetto, A; Nomdedeu, J; Bulian, P; Grossi, A; Zaja, F; Pozzato, G; Laurenti, L; Efremov, Dg; Di Raimondo, F; Marasca, Roberto; Forconi, F; Del Poeta, G; Gaidano, G; Gattei, Valter. - In: BLOOD. - ISSN 1528-0020. - STAMPA. - 121:24(2013), pp. 4902-4905. [10.1182/blood-2013-02-486209]
Rossi, D; Spina, Vincenzo; Bomben, R; Rasi, S; Dal Bo, M; Bruscaggin, A; Rossi, Fm; Monti, S; Degan, M; Ciardullo, C; Serra, R; Zucchetto, A; Nomdedeu...espandi
File in questo prodotto:
File Dimensione Formato  
Rossi Blood 2013 (association BCR stereotyped and new mutations).pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.11 MB
Formato Adobe PDF
1.11 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1081822
Citazioni
  • ???jsp.display-item.citation.pmc??? 45
  • Scopus 112
  • ???jsp.display-item.citation.isi??? 107
social impact